Ebb Therapeutics (Formerly Known As Cerêve, Inc.)
2555 Smallman Street
About Ebb Therapeutics (Formerly Known As Cerêve, Inc.)Ebb Therapeutics is a privately held company founded in 2008 by Eric Nofzinger, M.D. The company’s technology was inspired by Dr. Nofzinger’s pioneering brain imaging studies on patients with insomnia. With more than a century of collective experience in the sleep space, the Ebb Therapeutics team is on a mission to help everyone get the deep, refreshing sleep needed to take on tomorrow. Ebb was funded in part by a grant from the National Institutes of Health as well as by private equity and venture capital firms KKR, Arboretum Ventures, Versant Ventures and Partner Ventures.
Founder: Eric Nofzinger
FOLLOW EBB THERAPEUTICS:
Tweets by Ebb Therapeutics
6 articles with Ebb Therapeutics (Formerly Known As Cerêve, Inc.)
8/23/2019Biopharma companies strengthen their senior leadership teams and boards of directors with this week's appointments.
Ebb Therapeutics, a med-tech start-up that develops innovative products designed to help the sleep-deprived millions, announces that its added Eduard Röösli as its new President & CEO, effective immediately.
Ebb Therapeutics announces that its added Ray Huggenberger to its Board of Directors.
Ebb Therapeutics, announced today the appointment of Elise Wilfinger as its Chief Marketing Officer.